Progenics Pharmaceuticals Inc., engaged in the development and commercialization of therapeutic products to treat debilitating conditions and life-threatening diseases, today provided an update of the safety and efficacy endpoints achieved from its phase III study of RELISTOR (methylnaltrexone) for the … Continue reading →

Hollysys Automation Technologies Ltd., a leading provider of automation and control technologies and applications in China, has signed a stock purchase agreement (SPA) to acquire 100 percent ownership of Concord Corporation Pte Ltd. and its group of companies (CCPL) for … Continue reading →

Located in XI’AN, China, this up-and-coming company has quickly gained a reputation as a leading non-state-owned integrated energy company. Today, China Integrated Energy took a major step towards prominence when they announced that Jeff Chan will replace Albert Pu as … Continue reading →

New Energy Systems Group reported a strong year over year increase in sales and earnings in the first quarter of 2011. The company also confirmed financial guidance for 2011 and provided an update on business trends for the year. New … Continue reading →

Yesterday, Callidus Software, Inc. announced that it has been experiencing continued growth across Asia-Pacific in the adoption of its Sales Performance Management (SPM) suite of software. Callidus has signed deals with five multinational financial services companies in less than a … Continue reading →

Affymetrix Inc., a provider of technology used by top pharmaceutical, diagnostic and biotechnology companies, as well as by academic, government and nonprofit research institutes, has rolled-out its Axiom myDesign Targeted Genotyping Arrays to help researchers study disease mutations and characterize … Continue reading →

NetSol Technologies, Inc., a company that designs, develops, and markets software products for various industries worldwide, announced that it has signed a Memorandum of Understanding (MOU) with Brasilinvest Group, a large private business development company headquartered in Brazil, to create … Continue reading →

PURE Bioscience, developers of bioscience products for combating stubborn bacteria such as Staph (MRSA), announced today that its patented antimicrobial product SDC (silver dihydrogen citrate) has been shown to be effective based upon tests conducted by the University of Medicine … Continue reading →

Agenus Inc. just announced that it will be presenting new data from a Phase 2 trial of the Prophage G-200 vaccine (HSPPC-96; vitespen) in recurrent glioma. The company intends making a poster presentation during the 2011 ASCO Annual Meeting, slated … Continue reading →